The decision to cancel hundreds of millions of dollars in investment in messenger RNA (mRNA) vaccines by federal health officials has stirred controversy in the scientific community. Health secretary Robert F. Kennedy Jr. cited concerns about the efficacy and safety of mRNA vaccines as the primary reason for this drastic move. The Department of Health and Human Services (HHS) justified their decision by referencing a 181-page list of studies compiled by various individuals, including those who have been critical of Covid-19 public health interventions such as lockdowns and mRNA vaccines.
The studies cited in the list have been met with skepticism by other scientists who argue that mRNA vaccines are generally safe. The list, which was last updated on July 1, was reportedly used as research for a book titled âToxic Shot: Facing the Dangers of the COVID âVaccines.ââ Among the contributors to the list is Steven Hatfill, a virologist who previously recommended hydroxychloroquine as a Covid-19 treatment without substantial evidence of its effectiveness.
In a video announcement, Kennedy directed the Biomedical Advanced Research and Development Authority (BARDA) to cancel 22 grants supporting mRNA vaccine development, totaling $500 million. Instead, the administration plans to focus on research using a whole killed virus approach for vaccine development. This decision has raised concerns among public health experts who believe that mRNA vaccine technology played a crucial role in saving lives during the pandemic due to its ability to deliver vaccines quickly.
The studies cited by HHS suggest that the spike protein produced by mRNA vaccines could be harmful independently of the rest of the virus. However, other Covid vaccines that do not use mRNA technology also target the spike protein in the SARS-CoV-2 virus. The list of contributors to the research includes individuals like Martin Wucher, a dentist critical of Covid lockdowns, and Erik Sass, who has advocated for the use of hydroxychloroquine as a Covid treatment.
Overall, the decision to halt investment in mRNA vaccines has sparked debate within the scientific community. While some believe that alternative vaccine approaches may be safer, others argue that mRNA technology has proven to be effective in responding to public health crises. The implications of this shift in research focus remain to be seen, as experts continue to assess the potential impact on public health and scientific progress.
